The agency issued priority vouchers for three experimental new drugs using psilocybin and methylone, amid Trump's pro-psychedelics push. https://t.co/FN6lmlTfFT— Fast Company (@FastCompany) April 24, 2026
The agency issued priority vouchers for three experimental new drugs using psilocybin and methylone, amid Trump's pro-psychedelics push.
@FastCompany·X: @FastCompany··1 min read
X
Continue reading on X: @FastCompany
This article was sourced from X: @FastCompany's RSS feed. Visit the original for the complete story.